Skip to main content
Erschienen in: Metabolic Brain Disease 4/2018

27.03.2018 | Original Article

Probiotic treatment reduces the autistic-like excitation/inhibition imbalance in juvenile hamsters induced by orally administered propionic acid and clindamycin

verfasst von: Afaf El-Ansary, Abir Ben Bacha, Geir Bjørklund, Nora Al-Orf, Ramesa Shafi Bhat, Nadine Moubayed, Kawther Abed

Erschienen in: Metabolic Brain Disease | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Increasing evidence suggests that the gut microbiota plays a key role in the central nervous system (CNS), and alterations of the gut microbiota composition due to environmental factors can contribute to neurodevelopmental disorders. Animal modeling may help to identify drugs that can normalize the altered gut microbiota and thereby ameliorate abnormal brain signaling pathways. The purpose of the present study was to investigate the therapeutic potency of probiotics such as Bifidobacteria and Lactobacilli on glutamate excitotoxicity as a neurotoxic effect induced by clindamycin and propionic acid (PPA) in juvenile hamsters. Fifty young golden Syrian hamsters weighing between 60 and 70 g were enrolled in the study. The hamsters were randomly divided into five groups, each with ten hamsters. The hamsters in the control group only received phosphate-buffered saline orally. The PPA-treated group received a neurotoxic dose of 250 mg PPA/kg body weight (BW)/day for three days. The clindamycin-treated group received 30 mg clindamycin/kg BW as a single orogastric dose on the day the experiment started. The two therapeutic groups received the same doses of PPA and clindamycin followed by 0.2 g probiotic/kg BW for three weeks. Biochemical parameters related to glutamate excitotoxicity were investigated in brain homogenates from each group of hamsters. Additionally, the development of pathogenic bacteria was monitored in stool samples from all groups. The microbiology results of the present study revealed descriptive changes in the fecal microbiota and the appearance of Clostridium species in the hamsters treated with clindamycin and PPA. Additionally, the effectiveness of the probiotic in the restoration of the normal gut microbiota was demonstrated. Moreover, clindamycin and PPA were found to induce a significant depletion of Mg2+ and γ-aminobutyric acid (GABA) and a remarkable increase in the Na+/Mg2+ and glutamate/GABA ratios but non-significant changes in the absolute levels of K+, Na+ and glutamate. The bacteria overgrowth induced by PPA and clindamycin in the present study effectively showed signs of neuronal toxicity. The study indicates that probiotics can be used safely to ameliorate glutamate excitotoxicity mostly through increasing depleted GABA and Mg2+ and decreasing the excitatory neurotransmitter, glutamate.
Literatur
Zurück zum Zitat Al-Suwailem EA (2016) Understanding glutamate signaling defects in propionic acid-orally administered wistar rat pups as animal model of autism. Biochemistry Department, College of Science, King Saud University, Riyadh, Master thesis Al-Suwailem EA (2016) Understanding glutamate signaling defects in propionic acid-orally administered wistar rat pups as animal model of autism. Biochemistry Department, College of Science, King Saud University, Riyadh, Master thesis
Zurück zum Zitat Ault B, Evans RH, Francis AA, Oakes DJ, Watkins JC (1980) Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations. J Physiol 307:413–428CrossRefPubMedPubMedCentral Ault B, Evans RH, Francis AA, Oakes DJ, Watkins JC (1980) Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations. J Physiol 307:413–428CrossRefPubMedPubMedCentral
Zurück zum Zitat Blaylock R (1999) Food additive excitotoxins and degenerative brain disorders. Med Sentinel 4:212–215 Blaylock R (1999) Food additive excitotoxins and degenerative brain disorders. Med Sentinel 4:212–215
Zurück zum Zitat Brudnak MA (2002) Probiotics as an adjuvant to detoxification protocols. Med Hypotheses 58:382–395CrossRefPubMed Brudnak MA (2002) Probiotics as an adjuvant to detoxification protocols. Med Hypotheses 58:382–395CrossRefPubMed
Zurück zum Zitat Casanova MF, van Kooten IA, Switala AE, van Engeland H, Heinsen H, Steinbusch HW, Hof PR, Trippe J, Stone J, Schmitz C (2009) Minicolumnar abnormalities in autism. Acta Neuropathol 112:287–303CrossRef Casanova MF, van Kooten IA, Switala AE, van Engeland H, Heinsen H, Steinbusch HW, Hof PR, Trippe J, Stone J, Schmitz C (2009) Minicolumnar abnormalities in autism. Acta Neuropathol 112:287–303CrossRef
Zurück zum Zitat Daghestani MH, Selim ME, Abd-Elhakim YM, Said EN, Abd El-Hameed NE, Khalil SR, El-Tawil OS (2017) The role of apitoxin in alleviating propionic acid-induced neurobehavioral impairments in rat pups: the expression pattern of Reelin gene. Biomed Pharmacother 93:48–56CrossRefPubMed Daghestani MH, Selim ME, Abd-Elhakim YM, Said EN, Abd El-Hameed NE, Khalil SR, El-Tawil OS (2017) The role of apitoxin in alleviating propionic acid-induced neurobehavioral impairments in rat pups: the expression pattern of Reelin gene. Biomed Pharmacother 93:48–56CrossRefPubMed
Zurück zum Zitat de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R (2014) Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37:197–206CrossRefPubMed de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R (2014) Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37:197–206CrossRefPubMed
Zurück zum Zitat Douglas LC, Sanders ME (2008) Probiotics and prebiotics in dietetics practice. J Am Diet Assoc 108:510–521CrossRefPubMed Douglas LC, Sanders ME (2008) Probiotics and prebiotics in dietetics practice. J Am Diet Assoc 108:510–521CrossRefPubMed
Zurück zum Zitat Dube L, Granry JC (2003) The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth 50:732–746CrossRefPubMed Dube L, Granry JC (2003) The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth 50:732–746CrossRefPubMed
Zurück zum Zitat Durlach J, Bac P (1997) Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Yasui M, Strong MJ, Ota K, Verity MA (eds) Mineral and metal neurotoxicology. CRC press, Boca Raton, pp 201–209 Durlach J, Bac P (1997) Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Yasui M, Strong MJ, Ota K, Verity MA (eds) Mineral and metal neurotoxicology. CRC press, Boca Raton, pp 201–209
Zurück zum Zitat El-Ansary (2016) A data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients. Data Brief 7:111–116CrossRefPubMedPubMedCentral El-Ansary (2016) A data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients. Data Brief 7:111–116CrossRefPubMedPubMedCentral
Zurück zum Zitat Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD (2009) GABA(a) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 39:223–230CrossRefPubMed Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD (2009) GABA(a) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 39:223–230CrossRefPubMed
Zurück zum Zitat Filpa V, Moro E, Protasoni M, Crema F, Frigo G, Giaroni C (2016) Role of glutamatergic neurotransmission in the enteric nervous system and brain-gut axis in health and disease. Neuropharmacology 111:14–33CrossRefPubMed Filpa V, Moro E, Protasoni M, Crema F, Frigo G, Giaroni C (2016) Role of glutamatergic neurotransmission in the enteric nervous system and brain-gut axis in health and disease. Neuropharmacology 111:14–33CrossRefPubMed
Zurück zum Zitat Foley KA, MacFabe DF, Kavaliers M, Ossenkopp KP (2015) Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: relevance to autism spectrum disorders. Behav Brain Res 278:244–256. https://doi.org/10.1016/j.bbr.2014.09.032 CrossRefPubMed Foley KA, MacFabe DF, Kavaliers M, Ossenkopp KP (2015) Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: relevance to autism spectrum disorders. Behav Brain Res 278:244–256. https://​doi.​org/​10.​1016/​j.​bbr.​2014.​09.​032 CrossRefPubMed
Zurück zum Zitat Gatto CL, Broadie K (2010) Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 7:2–4 Gatto CL, Broadie K (2010) Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 7:2–4
Zurück zum Zitat Han S, Tai C, Westenbroek RE, Yu FH, Cheah CS, Potter GB, Rubenstein JL, Scheuer T, de la Iglesia HO, Catterall WA (2012) Autistic-like behaviour in Scn1a1/− mice and rescue by enhanced GABA-mediated neurotransmission. Nature 489:385–390CrossRefPubMedPubMedCentral Han S, Tai C, Westenbroek RE, Yu FH, Cheah CS, Potter GB, Rubenstein JL, Scheuer T, de la Iglesia HO, Catterall WA (2012) Autistic-like behaviour in Scn1a1/− mice and rescue by enhanced GABA-mediated neurotransmission. Nature 489:385–390CrossRefPubMedPubMedCentral
Zurück zum Zitat Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document: the international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514CrossRefPubMed Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document: the international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514CrossRefPubMed
Zurück zum Zitat Ito S, Ogiwara I, Yamada K, Miyamoto H, Hensch TK, Osawa M, Yamakawa K (2013) Mouse with Nav1.1 haploinsufficiency, a model for Dravet syndrome, exhibits lowered sociability and learning impairment. Neurobiol Dis 49:29–40CrossRefPubMed Ito S, Ogiwara I, Yamada K, Miyamoto H, Hensch TK, Osawa M, Yamakawa K (2013) Mouse with Nav1.1 haploinsufficiency, a model for Dravet syndrome, exhibits lowered sociability and learning impairment. Neurobiol Dis 49:29–40CrossRefPubMed
Zurück zum Zitat Kim JW, Seung H, Kim KC, Gonzales EL, Oh HA, Yang SM, Ko MJ, Han SH, Banerjee S, Shin CY (2017) Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism. Neuropharmacology 113(Pt A):71–81 Kim JW, Seung H, Kim KC, Gonzales EL, Oh HA, Yang SM, Ko MJ, Han SH, Banerjee S, Shin CY (2017) Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism. Neuropharmacology 113(Pt A):71–81
Zurück zum Zitat Krnjevic K, Lamour Y, MacDonald JF, Nistri A, Puil E, Werman R (1979) Intracellular divalent cations and neuronal excitability. Can J Physiol Pharmacol 57:957–972CrossRefPubMed Krnjevic K, Lamour Y, MacDonald JF, Nistri A, Puil E, Werman R (1979) Intracellular divalent cations and neuronal excitability. Can J Physiol Pharmacol 57:957–972CrossRefPubMed
Zurück zum Zitat Li Q, Zhou JM (2016) The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 324:131–139CrossRefPubMed Li Q, Zhou JM (2016) The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 324:131–139CrossRefPubMed
Zurück zum Zitat Li KX, Lu YM, Xu ZH, Zhang J, Zhu JM, Zhang JM, Cao SX, Chen XJ, Chen Z, Luo JH, Duan S, Li XM (2011) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci 15:267–273CrossRefPubMed Li KX, Lu YM, Xu ZH, Zhang J, Zhu JM, Zhang JM, Cao SX, Chen XJ, Chen Z, Luo JH, Duan S, Li XM (2011) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci 15:267–273CrossRefPubMed
Zurück zum Zitat Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin F (2015) Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310:561–577CrossRefPubMed Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin F (2015) Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310:561–577CrossRefPubMed
Zurück zum Zitat Liu YW, Liu WH, Wu CC, Juan YC, Wu YC, Tsai HP, Wang S, Tsai YC (2016) Psychotropic effects of lactobacillus plantarum PS128 in early life-stressed and naive adult mice. Brain Res:1631:1–163112 Liu YW, Liu WH, Wu CC, Juan YC, Wu YC, Tsai HP, Wang S, Tsai YC (2016) Psychotropic effects of lactobacillus plantarum PS128 in early life-stressed and naive adult mice. Brain Res:1631:1–163112
Zurück zum Zitat MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176:149–169CrossRefPubMed MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176:149–169CrossRefPubMed
Zurück zum Zitat MacFabe DF, Rodríguez-Capote K, Hoffman JE, Franklin AE, Mohammad-Asef Y, Taylor AR, Boon F, Cain DP, Kavaliers M, Possmayer F, Ossenkopp KP (2008) Novel rodent model of autism: Intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am J Biochem Biotechnol 4:146–166. https://doi.org/10.3844/ajbbsp.2008.146.166 CrossRef MacFabe DF, Rodríguez-Capote K, Hoffman JE, Franklin AE, Mohammad-Asef Y, Taylor AR, Boon F, Cain DP, Kavaliers M, Possmayer F, Ossenkopp KP (2008) Novel rodent model of autism: Intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am J Biochem Biotechnol 4:146–166. https://​doi.​org/​10.​3844/​ajbbsp.​2008.​146.​166 CrossRef
Zurück zum Zitat MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP (2011) Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 217:47–54CrossRefPubMed MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP (2011) Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 217:47–54CrossRefPubMed
Zurück zum Zitat Michelle M, Susan S, Stuart J, Dale N (2003) Susceptibility of hamsters to human pathogenic clostridium difficile strainB1 following clindamycin, ampicillin or ceftriaxone administration. Anaerobe 9:91–95CrossRef Michelle M, Susan S, Stuart J, Dale N (2003) Susceptibility of hamsters to human pathogenic clostridium difficile strainB1 following clindamycin, ampicillin or ceftriaxone administration. Anaerobe 9:91–95CrossRef
Zurück zum Zitat Morris ME (1992) Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms. Magnes Res 5:303–313PubMed Morris ME (1992) Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms. Magnes Res 5:303–313PubMed
Zurück zum Zitat Oberman LM (2012) mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders. Expert Opin Investig Drugs 21:1819–1825CrossRefPubMed Oberman LM (2012) mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders. Expert Opin Investig Drugs 21:1819–1825CrossRefPubMed
Zurück zum Zitat Parracho HMRT, Gibson GR, Knott F, Bosscher D, Kleerebezem M, McCartney AL (2010) A double-blind, placebo controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. Int J Probiotics Prebiotics 5:69–74 Parracho HMRT, Gibson GR, Knott F, Bosscher D, Kleerebezem M, McCartney AL (2010) A double-blind, placebo controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. Int J Probiotics Prebiotics 5:69–74
Zurück zum Zitat Payne S, Gibson G, Wynne A, Hudspith B, Brostoff J, Tuohy K (2003) In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and lactobacillus plantarum LPK. Curr Issues Intest Microbiol 4:1–8PubMed Payne S, Gibson G, Wynne A, Hudspith B, Brostoff J, Tuohy K (2003) In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and lactobacillus plantarum LPK. Curr Issues Intest Microbiol 4:1–8PubMed
Zurück zum Zitat Rubenstein JL, Merzenich MM (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2:255–267CrossRefPubMed Rubenstein JL, Merzenich MM (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2:255–267CrossRefPubMed
Zurück zum Zitat Savignac HM, Kiely B, Dinan TG, Cryan JF (2014) Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil 26:1615–1627CrossRefPubMed Savignac HM, Kiely B, Dinan TG, Cryan JF (2014) Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil 26:1615–1627CrossRefPubMed
Zurück zum Zitat Stein DG, Glasier MM (1992) An overview of developments in research on recovery from brain injury. In: Rose FD, Johnson DA (eds) Recovery from brain damage reflections and directions. Plenum press, New York, pp 1–22 Stein DG, Glasier MM (1992) An overview of developments in research on recovery from brain injury. In: Rose FD, Johnson DA (eds) Recovery from brain damage reflections and directions. Plenum press, New York, pp 1–22
Zurück zum Zitat Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabrò A, De Filippo C (2017) New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5(1):24CrossRefPubMedPubMedCentral Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabrò A, De Filippo C (2017) New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5(1):24CrossRefPubMedPubMedCentral
Zurück zum Zitat Tan GH, Liu YY, Hu XL, Yin DM, Mei L, Xiong ZQ (2011) Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbuminexpressing interneurons. Nat Neurosci 15:258–266CrossRefPubMed Tan GH, Liu YY, Hu XL, Yin DM, Mei L, Xiong ZQ (2011) Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbuminexpressing interneurons. Nat Neurosci 15:258–266CrossRefPubMed
Zurück zum Zitat Vuong HE, Hsiao EY (2017) Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry 81:411–423CrossRefPubMed Vuong HE, Hsiao EY (2017) Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry 81:411–423CrossRefPubMed
Zurück zum Zitat Yasui M, Ota K, Murphy VA (1997) Magnesium-related neurological disorders. In: Yasui M, Strong MJ, Ota K, Verity MA (eds) Mineral and metal neurotoxicology. CRC press, Boca Raton, pp 219–226 Yasui M, Ota K, Murphy VA (1997) Magnesium-related neurological disorders. In: Yasui M, Strong MJ, Ota K, Verity MA (eds) Mineral and metal neurotoxicology. CRC press, Boca Raton, pp 219–226
Zurück zum Zitat Zhang Y, Bonnan A, Bony G, Ferezou I, Pietropaolo S, Ginger M, Sans N, Rossier J, Oostra B, LeMasson G, Frick A (2014) Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(−/y) mice. Nat Neurosci 17:1701–1709CrossRefPubMed Zhang Y, Bonnan A, Bony G, Ferezou I, Pietropaolo S, Ginger M, Sans N, Rossier J, Oostra B, LeMasson G, Frick A (2014) Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(−/y) mice. Nat Neurosci 17:1701–1709CrossRefPubMed
Metadaten
Titel
Probiotic treatment reduces the autistic-like excitation/inhibition imbalance in juvenile hamsters induced by orally administered propionic acid and clindamycin
verfasst von
Afaf El-Ansary
Abir Ben Bacha
Geir Bjørklund
Nora Al-Orf
Ramesa Shafi Bhat
Nadine Moubayed
Kawther Abed
Publikationsdatum
27.03.2018
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 4/2018
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-018-0212-8

Weitere Artikel der Ausgabe 4/2018

Metabolic Brain Disease 4/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.